BRIEF published on 07/25/2024 at 12:32, 2 years 3 months ago Novacyt publishes its unaudited half-yearly activity report Acquisition R&D Turnover Novacyt Semestrial Report
BRIEF published on 07/25/2024 at 12:29, 2 years 3 months ago Novacyt Announces Half Year Trading Update for 2024 Revenue Growth Strategic Initiatives Regulatory Approvals Financial Update New Products
PRESS RELEASE published on 07/25/2024 at 12:24, 2 years 3 months ago Half Year Trading Update Novacyt S.A. announces unaudited trading update for H1 2024, showcasing revenue growth, cash position, cost-saving measures, and strategic progress across clinical, instrumentation, and R&D segments Revenue Growth Trading Update Cost-saving Measures Novacyt S.A. R&D Progress
BRIEF published on 07/22/2024 at 12:42, 2 years 3 months ago Results of the Novacyt Annual General Meeting Nomination Resolutions General Assembly Molecular Diagnostics Novacyt
BRIEF published on 07/22/2024 at 12:41, 2 years 3 months ago Novacyt Announces AGM Results and New Board Appointments AGM Executive Directors Molecular Diagnostics Board Appointments Novacyt
PRESS RELEASE published on 07/22/2024 at 12:36, 2 years 3 months ago Result of AGM Novacyt S.A. announces successful AGM with new Executive Directors. Visit the company's website for AGM voting results Voting Results AGM Executive Directors Molecular Diagnostics Novacyt
BRIEF published on 07/18/2024 at 12:40, 2 years 3 months ago Novacyt announces the financial impacts of the agreement with DHSC Treasury VAT Financial Agreement Novacyt DHSC
BRIEF published on 07/18/2024 at 12:38, 2 years 3 months ago Novacyt Announces Financial Impact of DHSC Settlement Financial Impact Novacyt DHSC Settlement VAT Reclaim Clinical Diagnostics
PRESS RELEASE published on 07/18/2024 at 12:33, 2 years 3 months ago AGM Statement on Impact of DHSC Settlement Novacyt provides update on AGM statement regarding DHSC settlement impact, anticipating a potential £7m net cash increase from VAT reclaim. Details of income statement and cash flow implications disclosed Novacyt DHSC Settlement VAT Reclaim AGM Statement Net Cash Increase
BRIEF published on 06/26/2024 at 15:40, 2 years 4 months ago Novacyt Reschedules AGM to 18 July Shareholders AGM Novacyt Online Meeting Rescheduled
Published on 11/02/2026 at 12:30, 25 minutes ago Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
Published on 11/02/2026 at 12:10, 45 minutes ago Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
Published on 10/30/2026 at 23:35, 2 days 13 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 13 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 11/02/2026 at 12:45, 10 minutes ago Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial
Published on 11/02/2026 at 12:37, 18 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 11/02/2026 at 12:30, 25 minutes ago Immunic to Participate in Investor Conferences in November
Published on 11/02/2026 at 12:05, 50 minutes ago Trade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering
Published on 10/30/2026 at 23:00, 2 days 13 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 18 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days ago Capital increase through exercise of subscription rights
